Cargando…

Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study

OBJECTIVES: A more nuanced understanding of contributors to covert contraceptive use remains critical to protecting covert users and reducing its necessity. This study aimed to examine the overall prevalence of covert use, and sociodemographic characteristics associated with covert vs overt use acro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarnak, Dana O., Gummerson, Elizabeth, Wood, Shannon N., OlaOlorun, Funmilola M., Kibira, Simon Peter Sebina, Zimmerman, Linnea A., Anglewicz, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127266/
https://www.ncbi.nlm.nih.gov/pubmed/35620730
http://dx.doi.org/10.1016/j.conx.2022.100077
_version_ 1784712313590251520
author Sarnak, Dana O.
Gummerson, Elizabeth
Wood, Shannon N.
OlaOlorun, Funmilola M.
Kibira, Simon Peter Sebina
Zimmerman, Linnea A.
Anglewicz, Philip
author_facet Sarnak, Dana O.
Gummerson, Elizabeth
Wood, Shannon N.
OlaOlorun, Funmilola M.
Kibira, Simon Peter Sebina
Zimmerman, Linnea A.
Anglewicz, Philip
author_sort Sarnak, Dana O.
collection PubMed
description OBJECTIVES: A more nuanced understanding of contributors to covert contraceptive use remains critical to protecting covert users and reducing its necessity. This study aimed to examine the overall prevalence of covert use, and sociodemographic characteristics associated with covert vs overt use across multiple geographies in sub-Saharan Africa and Asia. STUDY DESIGN: Performance Monitoring for Action (PMA) is one of the few nationally representative surveys that measures covert use across socially diverse contexts via a direct question. Utilizing PMA 2019–2020 phase 1 data from Burkina Faso, Côte D'Ivoire, Kenya, Democratic Republic of Congo (DRC; Kinshasa and Kongo Central regions), Uganda, Nigeria (Kano and Lagos), Niger, and Rajasthan, we estimated overall prevalence of covert use. We conducted bivariate analyses and multivariate logistic regressions for 6 sites, comparing the odds of covert use with overt use among users of contraception by sociodemographic characteristics. RESULTS: Covert use ranged from 1% in Rajasthan to 16% in Burkina Faso. Marital status was the only sociodemographic characteristic consistently associated with type of use across sites. Specifically, polygynous marriage (compared to monogamous) increased odds of using covertly, ranging from adjusted odds ratio (aOR) of 1.8 [95% confidence interval (CI) 1.2–2.7] in Burkina Faso to 6.2 [95% CI 2.9–13.3] in Kinshasa. Unmarried women with partners or boyfriends were also more likely to be using covertly compared with their monogamously married counterparts in all sites (aORs ranged from 2.2 [95% CI 1.0–4.7] in Uganda to 4.4 [95% CI 1.7–11.0] in Kinshasa). CONCLUSION: Understanding factors associated with covert use has programmatic and policy implications for women's reproductive autonomy. IMPLICATIONS: Covert use is a common phenomenon across most sites, representing a small but programmatically important contingent of users. Family planning providers and programs must protect access to and maintain privacy of reproductive services to this population, but should also focus on creating interventions and environments that support overt use.
format Online
Article
Text
id pubmed-9127266
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91272662022-05-25 Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study Sarnak, Dana O. Gummerson, Elizabeth Wood, Shannon N. OlaOlorun, Funmilola M. Kibira, Simon Peter Sebina Zimmerman, Linnea A. Anglewicz, Philip Contracept X Original Research Article OBJECTIVES: A more nuanced understanding of contributors to covert contraceptive use remains critical to protecting covert users and reducing its necessity. This study aimed to examine the overall prevalence of covert use, and sociodemographic characteristics associated with covert vs overt use across multiple geographies in sub-Saharan Africa and Asia. STUDY DESIGN: Performance Monitoring for Action (PMA) is one of the few nationally representative surveys that measures covert use across socially diverse contexts via a direct question. Utilizing PMA 2019–2020 phase 1 data from Burkina Faso, Côte D'Ivoire, Kenya, Democratic Republic of Congo (DRC; Kinshasa and Kongo Central regions), Uganda, Nigeria (Kano and Lagos), Niger, and Rajasthan, we estimated overall prevalence of covert use. We conducted bivariate analyses and multivariate logistic regressions for 6 sites, comparing the odds of covert use with overt use among users of contraception by sociodemographic characteristics. RESULTS: Covert use ranged from 1% in Rajasthan to 16% in Burkina Faso. Marital status was the only sociodemographic characteristic consistently associated with type of use across sites. Specifically, polygynous marriage (compared to monogamous) increased odds of using covertly, ranging from adjusted odds ratio (aOR) of 1.8 [95% confidence interval (CI) 1.2–2.7] in Burkina Faso to 6.2 [95% CI 2.9–13.3] in Kinshasa. Unmarried women with partners or boyfriends were also more likely to be using covertly compared with their monogamously married counterparts in all sites (aORs ranged from 2.2 [95% CI 1.0–4.7] in Uganda to 4.4 [95% CI 1.7–11.0] in Kinshasa). CONCLUSION: Understanding factors associated with covert use has programmatic and policy implications for women's reproductive autonomy. IMPLICATIONS: Covert use is a common phenomenon across most sites, representing a small but programmatically important contingent of users. Family planning providers and programs must protect access to and maintain privacy of reproductive services to this population, but should also focus on creating interventions and environments that support overt use. Elsevier 2022-05-06 /pmc/articles/PMC9127266/ /pubmed/35620730 http://dx.doi.org/10.1016/j.conx.2022.100077 Text en © 2022 The Author(s). Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research Article
Sarnak, Dana O.
Gummerson, Elizabeth
Wood, Shannon N.
OlaOlorun, Funmilola M.
Kibira, Simon Peter Sebina
Zimmerman, Linnea A.
Anglewicz, Philip
Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title_full Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title_fullStr Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title_full_unstemmed Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title_short Prevalence and characteristics of covert contraceptive use in the Performance Monitoring for Action multi-country study
title_sort prevalence and characteristics of covert contraceptive use in the performance monitoring for action multi-country study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127266/
https://www.ncbi.nlm.nih.gov/pubmed/35620730
http://dx.doi.org/10.1016/j.conx.2022.100077
work_keys_str_mv AT sarnakdanao prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT gummersonelizabeth prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT woodshannonn prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT olaolorunfunmilolam prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT kibirasimonpetersebina prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT zimmermanlinneaa prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy
AT anglewiczphilip prevalenceandcharacteristicsofcovertcontraceptiveuseintheperformancemonitoringforactionmulticountrystudy